![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - Market Wire
[ Mon, Apr 30th 2012
] - Market Wire
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
[ Mon, Apr 30th 2012
] - WOPRAI
Matthew Kaplan Maintained (UTHR) at Strong Buy with Decreased Target to $58 on, Apr 30th, 2012
Matthew Kaplan of Ladenburg Thalmann, Maintained "United Therapeutics Corporation" (UTHR) at Strong Buy with Decreased Target from $61 to $58 on, Apr 30th, 2012.
Matthew, nor any peers, have made any analyst calls on UTHR in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources
Similar Stocks and Investing Articles
[ Wed, Apr 25th 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Mon, Apr 16th 2012
] - WOPRAI
[ Thu, Apr 05th 2012
] - WOPRAI
[ Thu, Apr 05th 2012
] - WOPRAI
[ Tue, Mar 20th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI
[ Fri, Mar 16th 2012
] - WOPRAI
[ Thu, Mar 15th 2012
] - WOPRAI